{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:04Z","timestamp":1793296024005,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011769","name":"Scripps Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Perianal fistulizing Crohn\u2019s disease affects a third of patients with Crohn\u2019s disease and represents one of the most challenging complications to manage. This severe phenotype is characterized by aggressive disease behavior, high recurrence rates, frequent hospitalizations and surgical interventions, and profound impairment of quality of life, particularly affecting social and sexual function. The complex pathophysiology involves genetic susceptibility, immune dysregulation with elevated inflammatory cytokines, epithelial-to-mesenchymal transition, myofibroblast activation, and impaired wound healing mechanisms. Despite advances in anti-inflammatory and immunomodulatory therapies, current medical and surgical approaches achieve long-term fistula healing in only approximately 50% of patients. More than 90% of patients undergo multiple operative interventions, often with limited efficacy and risk of fecal incontinence. Anti-tumor necrosis factor agents, particularly infliximab, remain the cornerstone of medical therapy, yet more than 50% of patients lose response over time. Combination approaches with setons and biologics improve outcomes but remain suboptimal for many patients.These persistent limitations have prompted increasing interest in regenerative strategies aimed at restoring tissue integrity and enhancing local healing mechanisms. Mesenchymal stem cell therapy, particularly adipose-derived stem cells, has emerged as a promising approach, with clinical trials demonstrating complete fistula healing in the majority of cases and a favorable safety profile, but there are limitations with logistics of cell handling and negative late phase pivotal trials. This review evaluates the current landscape of novel regenerative therapies for perianal fistulizing Crohn\u2019s disease, including mesenchymal stem cell preparations, extracellular vesicle-based approaches, and adjunctive techniques.<\/jats:p>","DOI":"10.1007\/s10151-026-03318-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:43:04Z","timestamp":1778697784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Needles for healing: stem cells, platelet-enriched plasma, and fat injection in perianal fistulizing Crohn\u2019s disease"],"prefix":"10.1007","volume":"30","author":[{"given":"E.","family":"Takata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Lightner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"3318_CR1","doi-asserted-by":"publisher","unstructured":"Lightner AL, Irving PM, Lord GM, Betancourt A (2024) Stem cells and stem cell-derived factors for the treatment of inflammatory bowel disease with a particular focus on perianal fistulizing disease: a minireview on future perspectives. BioDrugs 38(4):527\u2013539. https:\/\/doi.org\/10.1007\/s40259-024-00661-6","DOI":"10.1007\/s40259-024-00661-6"},{"key":"3318_CR2","doi-asserted-by":"publisher","unstructured":"Obi M,  Lightner AL (2023) Surgical vs medical management of symptomatic anal fistulas in patients with Crohn\u2019s disease. In: Umanskiy K, Hyman N (eds), Difficult decisions in colorectal surgery. Springer International Publishing, p 13\u201337. https:\/\/doi.org\/10.1007\/978-3-031-42303-1_2","DOI":"10.1007\/978-3-031-42303-1_2"},{"issue":"5","key":"3318_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/ans.18231","volume":"93","author":"M De Gregorio","year":"2023","unstructured":"De Gregorio M, Tiang T, Lee T, Stellingwerf ME, Singh S, Thompson AJ et al (2023) Autologous fat graft injections for the treatment of perianal fistulas in Crohn\u2019s disease: a systematic review and single-arm meta-analysis. ANZ J Surg 93(5):1162\u20131168","journal-title":"ANZ J Surg"},{"issue":"4","key":"3318_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00261-016-0989-z","volume":"42","author":"IS Oliveira","year":"2017","unstructured":"Oliveira IS, Kilcoyne A, Price MC, Harisinghani M (2017) MRI features of perianal fistulas: is there a difference between Crohn\u2019s and non-Crohn\u2019s patients? Abdom Radiol 42(4):1162\u20131168","journal-title":"Abdom Radiol"},{"issue":"9","key":"3318_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/ibd\/izad195","volume":"30","author":"A Singh","year":"2024","unstructured":"Singh A, Midha V, Kochhar GS, Shen B, Sood A (2024) Management of perianal fistulizing Crohn\u2019s disease. Inflamm Bowel Dis 30(9):1579\u20131603","journal-title":"Inflamm Bowel Dis"},{"key":"3318_CR6","doi-asserted-by":"publisher","unstructured":"Schwartz DA, Lightner AL, Aswani-Omprakash T, Kotze PG, Mccurdy JD (2025) Better together: implementing a multidisciplinary approach to optimizing diagnosis and management of Crohn\u2019s perianal fistulas. Gastroenterology 168(4):640\u2013644.e1. https:\/\/doi.org\/10.1053\/j.gastro.2024.10.019","DOI":"10.1053\/j.gastro.2024.10.019"},{"issue":"8","key":"3318_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S2468-1253(25)00007-X","volume":"10","author":"LN Hanna","year":"2025","unstructured":"Hanna LN, Munster LJ, Joshi S, Wendelien van der Bilt JD, Buskens CJ, Hart A et al (2025) Isolated perianal Crohn\u2019s disease: a systematic review and expert consensus proposing novel diagnostic criteria and management advice. Lancet Gastroenterol Hepatol. 10(8):757\u2013768","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"6","key":"3318_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/ecco-jcc\/jjad008","volume":"17","author":"S Cao","year":"2023","unstructured":"Cao S, Colonna M, Deepak P (2023) Pathogenesis of perianal fistulising Crohn\u2019s disease: current knowledge, gaps in understanding, and future research directions. J Crohns Colitis 17(6):1010\u20131022","journal-title":"J Crohns Colitis"},{"issue":"3","key":"3318_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/apt.14814","volume":"48","author":"PJ Tozer","year":"2018","unstructured":"Tozer PJ, Lung P, Lobo AJ, Sebastian S, Brown SR, Hart AL et al (2018) Review article: pathogenesis of Crohn\u2019s perianal fistula-understanding factors impacting on success and failure of treatment strategies. Aliment Pharmacol Ther 48(3):260\u2013269","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3318_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz DA, Loftus EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR et al (2002) The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota. Gastroenterology 122(4):875\u2013880","journal-title":"Gastroenterology"},{"issue":"9624","key":"3318_CR11","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet Lond Engl 371(9624):1579\u20131586","journal-title":"Lancet Lond Engl"},{"key":"3318_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113841","volume":"179","author":"AC Sebbagh","year":"2021","unstructured":"Sebbagh AC, Rosenbaum B, P\u00e9r\u00e9 G, Alric H, Berger A, Wilhelm C et al (2021) Regenerative medicine for digestive fistulae therapy: benefits, challenges and promises of stem\/stromal cells and emergent perspectives via their extracellular vesicles. Adv Drug Deliv Rev 179:113841","journal-title":"Adv Drug Deliv Rev"},{"issue":"suppl_1","key":"3318_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx002.007","volume":"11","author":"M Serrero","year":"2017","unstructured":"Serrero M, Philandrianos C, Visee C, Veran J, Orsoni P, Sabatier F et al (2017) OP008 an innovative treatment for refractory perianal fistulas in Crohn\u2019s disease: local micro reinjection of autologous fat and adipose derived stromal vascular fraction. J Crohns Colitis 11(suppl_1):S5","journal-title":"J Crohns Colitis"},{"issue":"8","key":"3318_CR14","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H et al (2010) Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62(8):2467\u20132475","journal-title":"Arthritis Rheum"},{"issue":"18","key":"3318_CR15","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.3390\/ijms22189967","volume":"22","author":"E Buscail","year":"2021","unstructured":"Buscail E, Le Cosquer G, Gross F, Lebrin M, Bugarel L, Deraison C et al (2021) Adipose-derived stem cells in the treatment of perianal fistulas in Crohn\u2019s disease: rationale, clinical results and perspectives. Int J Mol Sci 22(18):9967","journal-title":"Int J Mol Sci"},{"issue":"22","key":"3318_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216040","volume":"24","author":"LN Zaripova","year":"2023","unstructured":"Zaripova LN, Midgley A, Christmas SE, Beresford MW, Pain C, Baildam EM et al (2023) Mesenchymal stem cells in the pathogenesis and therapy of autoimmune and autoinflammatory diseases. Int J Mol Sci 24(22):16040","journal-title":"Int J Mol Sci"},{"key":"3318_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy A, AboQuella NM, Wang H (2023) Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther 14:66","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"3318_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/DCR.0000000000002473","volume":"65","author":"WB Gaertner","year":"2022","unstructured":"Gaertner WB, Burgess PL, Davids JS, Lightner AL, Shogan BD, Sun MY et al (2022) The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of anorectal abscess, fistula-in-ano, and rectovaginal fistula. Dis Colon Rectum 65(8):964","journal-title":"Dis Colon Rectum"},{"key":"3318_CR19","doi-asserted-by":"crossref","unstructured":"Serclova Z, Garcia-Olmo D, Chen ST, Wexner S, Pan\u00e9s J, Wu C, et al (2024) OP18 Efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn\u2019s Disease: results from the global ADMIRE-CD II phase 3 study. J Crohns Colitis 18(Supplement_1):i34\u20135.","DOI":"10.1093\/ecco-jcc\/jjad212.0018"},{"key":"3318_CR20","doi-asserted-by":"publisher","unstructured":"Dawes AJ, Lightner AL (2024) Perianal fistulizing Crohn\u2019s disease: outcomes of surgical repairs and current state of stem cell-based therapies. Clin Colon Rectal Surg 38(2):126\u2013140. https:\/\/doi.org\/10.1055\/s-0044-1786543","DOI":"10.1055\/s-0044-1786543"},{"key":"3318_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13287-025-04272-y","volume":"16","author":"L Guillo","year":"2025","unstructured":"Guillo L, Gravier Dumonceau R, V\u00e9lier M, Serrero M, Grimaud F, Sabatier F et al (2025) Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn\u2019s disease: a systematic review and meta-analysis. Stem Cell Res Ther 16:152","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3318_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10151-025-03138-y","volume":"29","author":"SH Emile","year":"2025","unstructured":"Emile SH, Dourado J, Rogers P, Wignakumar A, Horesh N, Garoufalia Z et al (2025) Systematic review and meta-analysis of the efficacy and safety of stem cell treatment of anal fistulas. Tech Coloproctology 29(1):100","journal-title":"Tech Coloproctology"},{"issue":"6","key":"3318_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s40259-018-0311-4","volume":"32","author":"LJ Scott","year":"2018","unstructured":"Scott LJ (2018) Darvadstrocel: a review in treatment-refractory complex perianal fistulas in Crohn\u2019s disease. BioDrugs 32(6):627\u2013634","journal-title":"BioDrugs"},{"issue":"5","key":"3318_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","volume":"65","author":"D Garcia-Olmo","year":"2022","unstructured":"Garcia-Olmo D, Gilaberte I, Binek M, D Hoore AJL, Lindner D, Selvaggi F et al (2022) Follow-up study to evaluate the long-term safety and efficacy of Darvadstrocel (mesenchymal stem cell treatment) in patients with Perianal Fistulizing Crohn\u2019s Disease: ADMIRE-CD Phase 3 randomized controlled trial. Dis Colon Rectum 65(5):713\u2013720","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"3318_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2025-001880","volume":"12","author":"J Husman","year":"2025","unstructured":"Husman J, Wardenga M, Kirk S, Matthes K, Naumann B, Dobroschke J et al (2025) Long-term effectiveness of allogeneic bone marrow-derived mesenchymal stromal cell therapy for complex perianal and rectovaginal fistulas in Crohn\u2019s disease: a retrospective case series. BMJ Open Gastroenterol 12(1):e001880","journal-title":"BMJ Open Gastroenterol"},{"issue":"Supplement_1","key":"3318_CR26","doi-asserted-by":"publisher","first-page":"i34","DOI":"10.1093\/ecco-jcc\/jjad212.0018","volume":"18","author":"Z Serclova","year":"2024","unstructured":"Serclova Z, Garcia-Olmo D, Chen ST, Wexner S, Pan\u00e9s J, Wu C et al (2024) OP18 efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn\u2019s Disease: results from the global ADMIRE-CD II phase 3 study. J Crohns Colitis 18(Supplement_1):i34\u2013i35","journal-title":"J Crohns Colitis"},{"issue":"10051","key":"3318_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Assche GV, Colombel JF, Reinisch W, Baumgart DC et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388(10051):1281\u20131290","journal-title":"Lancet"},{"issue":"1","key":"3318_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5045\/br.2016.51.1.3","volume":"51","author":"NK Jain","year":"2016","unstructured":"Jain NK, Gulati M (2016) Platelet-rich plasma: a healing virtuoso. Blood Res 51(1):3\u20135","journal-title":"Blood Res"},{"key":"3318_CR29","doi-asserted-by":"crossref","unstructured":"Wu WS, Chen LR, Chen KH (2025) Platelet-rich plasma (PRP): Molecular mechanisms, actions and clinical applications in human body. Int J Mol Sci 26(21). Available from: https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10804","DOI":"10.3390\/ijms262110804"},{"issue":"12","key":"3318_CR30","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11605-019-04480-x","volume":"24","author":"F de la Portilla","year":"2020","unstructured":"de la Portilla F, Jim\u00e9nez-Salido A, Araujo-Miguez A, Maestre-Sanchez MV, Reyes-Diaz ML, Ramallo-Sol\u00eds I et al (2020) Autologous platelet-rich plasma in the treatment of perianal fistula in Crohn\u2019s disease. J Gastrointest Surg 24(12):2814\u20132821","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"3318_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/apt.17347","volume":"57","author":"JHC Arkenbosch","year":"2023","unstructured":"Arkenbosch JHC, van Ruler O, Dwarkasing RS, Fuhler GM, Schouten WR, van Oud-Alblas MB et al (2023) Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn\u2019s disease: a pilot study. Aliment Pharmacol Ther 57(7):783\u2013791","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"3318_CR32","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/ph17111519","volume":"17","author":"MC Mazzaro","year":"2024","unstructured":"Mazzaro MC, de Paula AEC, Pascoal LB, Genaro LM, Pereira IM, Rodrigues BL et al (2024) Optimizing treatment outcomes in Crohn\u2019s disease: a comprehensive systematic review and meta-analysis of regenerative therapies with emphasis on platelet-rich plasma. Pharmaceuticals 17(11):1519","journal-title":"Pharmaceuticals"},{"issue":"9","key":"3318_CR33","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1093\/ibd\/izaf011","volume":"31","author":"MTJ Bak","year":"2025","unstructured":"Bak MTJ, de Vries AC, Witjes CDM, Arkenbosch JHC, Dwarkasing RS, van Dongen JA et al (2025) Intraoperative autologous platelet-rich stroma injection as add-on to fistula curettage and closure of the internal orifice demonstrates a favorable outcome in long-term in patients suffering from therapy-refractory perianal Fistulizing Crohn\u2019s disease. Inflamm Bowel Dis 31(9):2390\u20132399","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"3318_CR34","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/ibd\/izae283","volume":"31","author":"S Laureti","year":"2025","unstructured":"Laureti S, Cappelli A, Isopi C, Gentilini L, Villani R, Sorbi G et al (2025) Autologous microfragmented adipose tissue injection in refractory complex Crohn\u2019s perianal fistulas: long-term results at 6.7 years mean follow-up. Inflamm Bowel Dis 31(7):1943\u20131951","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"3318_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jcol.2018.03.004","volume":"38","author":"MMR Tavares","year":"2018","unstructured":"Tavares MMR, Barbosa LER (2018) Adipose tissue-derived stem cells: a new approach to the treatment of Crohn\u2019s disease-associated perianal fistulae. J Coloproctology 38(3):240\u2013245","journal-title":"J Coloproctology"},{"issue":"6","key":"3318_CR36","doi-asserted-by":"publisher","first-page":"1340e","DOI":"10.1097\/PRS.0000000000009710","volume":"150","author":"JM Firriolo","year":"2022","unstructured":"Firriolo JM, Cond\u00e9-Green A, Pu LLQ (2022) Fat grafting as regenerative surgery: a current review. Plast Reconstr Surg 150(6):1340e-e1347","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"3318_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.70045","volume":"33","author":"A Arena","year":"2025","unstructured":"Arena A, Troise S, De Francesco F, Apolito M, Committeri U, Salzano G et al (2025) Fat graft as regenerative treatment of facial manifestations of systemic sclerosis: a systematic review on the role of adipose tissue-derived stem cells and on surgical outcomes to define a new standardised injection protocol. Wound Repair Regen 33(3):e70045","journal-title":"Wound Repair Regen"},{"issue":"2","key":"3318_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ibd\/izz051","volume":"26","author":"S Laureti","year":"2020","unstructured":"Laureti S, Gionchetti P, Cappelli A, Vittori L, Contedini F, Rizzello F et al (2020) Refractory complex Crohn\u2019s perianal fistulas: a role for autologous microfragmented adipose tissue injection. Inflamm Bowel Dis 26(2):321\u2013330","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"3318_CR39","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1053\/j.gastro.2019.02.005","volume":"156","author":"A Dige","year":"2019","unstructured":"Dige A, Hougaard HT, Agnholt J, Pedersen BG, Tencerova M, Kassem M et al (2019) efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 156(8):2208-2216.e1","journal-title":"Gastroenterology"},{"key":"3318_CR40","doi-asserted-by":"crossref","unstructured":"Bak M, Witjes C, Arkenbosch J, Dwarkasing R, van Dongen J, Fuhler G, et al (2024) P538-Platelet-rich stroma during surgery for treatment-refractory perianal fistulizing Crohn\u2019s disease: long-term outcomes of a pilot study. J Crohns Colitis 18(Supplement_1):i1050\u20131.","DOI":"10.1093\/ecco-jcc\/jjad212.0668"},{"key":"3318_CR41","doi-asserted-by":"crossref","unstructured":"Wainstein C, Quera R, Flux\u00e1 D, Kronberg U, Conejero A, L\u00f3pez-K\u00f6stner F, et al (2018) Stem cell therapy in refractory perineal Crohn\u2019s disease: long-term follow-up. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2018","DOI":"10.1111\/codi.14002"},{"issue":"1","key":"3318_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13287-022-02738-x","volume":"13","author":"L Guillo","year":"2022","unstructured":"Guillo L, Grimaud F, Houser F, Prost C, Jouve E, Philandrianos C et al (2022) Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease. Stem Cell Res Ther 13(1):67","journal-title":"Stem Cell Res Ther"},{"issue":"24","key":"3318_CR43","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.3748\/wjg.v27.i24.3643","volume":"27","author":"O Schwandner","year":"2021","unstructured":"Schwandner O (2021) Stem cell injection for complex anal fistula in Crohn\u2019s disease: a single-center experience. World J Gastroenterol 27(24):3643\u20133653","journal-title":"World J Gastroenterol"},{"key":"3318_CR44","doi-asserted-by":"crossref","unstructured":"Dewint P, Hansen BE, Verhey E, Oldenburg B, Hommes DW, Pierik M, et al (2014) Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI). 2014 Feb 1 [cited 2026 Feb 5]; Available from: https:\/\/gut.bmj.com\/content\/63\/2\/292.long","DOI":"10.1136\/gutjnl-2013-304488"},{"issue":"4","key":"3318_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/DCR.0000000000003190","volume":"67","author":"E Ram","year":"2024","unstructured":"Ram E, Zager Y, Carter D, Saukhat O, Anteby R, Nachmany I et al (2024) A prospective, single-arm study to evaluate the safety and efficacy of an autologous blood clot product in the treatment of anal fistula. Dis Colon Rectum 67(4):541","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"3318_CR46","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.14309\/ajg.0000000000002326","volume":"118","author":"AM Parian","year":"2023","unstructured":"Parian AM, Obi M, Fleshner P, Schwartz DA (2023) Management of perianal Crohn\u2019s Disease. Am J Gastroenterol 118(8):1323\u20131331","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3318_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3393\/ac.2021.02.08","volume":"37","author":"JL Lee","year":"2021","unstructured":"Lee JL, Yoon YS, Yu CS (2021) Treatment strategy for perianal fistulas in Crohn Disease patients: the surgeon\u2019s point of view. Ann Coloproctol 37(1):5\u201315","journal-title":"Ann Coloproctol"},{"key":"3318_CR48","unstructured":"Takata E (2026) Clinical injection technique for perianal fistulas. BioRender2026."},{"issue":"39","key":"3318_CR49","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i39.112229","volume":"31","author":"P Bhatnagar","year":"2025","unstructured":"Bhatnagar P, Elhariri S, Burud IAS, Eid N (2025) Stem cell- and extracellular vesicle-based therapies for perianal fistulizing Crohn\u2019s disease: an updated review. World J Gastroenterol 31(39):112229","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3318_CR50","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i9.100221","volume":"31","author":"P Bhatnagar","year":"2025","unstructured":"Bhatnagar P, Elhariri S, Burud IAS, Eid N (2025) Perianal fistulizing Crohn\u2019s disease: mechanisms and treatment options focusing on cellular therapy. World J Gastroenterol 31(9):100221","journal-title":"World J Gastroenterol"},{"key":"3318_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.859954","volume":"13","author":"S Johnson","year":"2022","unstructured":"Johnson S, Hoch JS, Halabi WJ, Ko J, Nolta J, Dave M (2022) Mesenchymal stem\/stromal cell therapy is more cost-effective than fecal diversion for treatment of perianal Crohn\u2019s Disease fistulas. Front Immunol 13:859954","journal-title":"Front Immunol"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-026-03318-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-026-03318-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-026-03318-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:04:37Z","timestamp":1783400677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-026-03318-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["3318"],"URL":"https:\/\/doi.org\/10.1007\/s10151-026-03318-4","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This review article involved no human participants, and therefore no consent to participate was required. All authors have reviewed the manuscript and provided their consent for its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}}],"article-number":"97"}}